Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy.

Regina MühleckSebastian SchollInken HilgendorfKarin SchrenkJakob HammersenJochen J FrietschMaximilian FleischmannHerbert G SayerAnita GlaserAndreas HochhausUlf Schnetzke

Published in: Journal of cancer research and clinical oncology (2021)

The Mito-FLAG salvage protocol represents an effective and feasible treatment regimen for r/r AML. Importantly, a high rate of transition to successful alloHSCT with the aim of long-term disease-free survival has been shown.

Keyphrases

acute myeloid leukemia
free survival
allogeneic hematopoietic stem cell transplantation
randomized controlled trial
acute lymphoblastic leukemia
locally advanced
multiple myeloma
radiation therapy